Cardinal Health launches the next generation of the Kendall Compression Series, Kendall SCD SmartFlow Compression System, to aid pain relating…
…
…
…
Cardinal Health buys two companies for nearly $4 bln…
Cardinal Healths first-quarter fiscal 2025 results benefit from solid Pharmaceutical and Specialty Solutions growth. However, OptumRx contract expiry hurts sales.…
Cardinal (CAH) delivered earnings and revenue surprises of 14.63% and 1.99%, respectively, for the quarter ended September 2024. Do the…
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
Cardinal Health and T2 Biosystems announce an agreement selecting the former to sell direct-from-blood diagnostics for the rapid detection of…
CAH is set to acquire Oncology Network for $1.115 billion, expanding its oncology offerings while supporting community-based cancer care across…
Cardinal Health to acquire Integrated Oncology Network for $1.12 billion…
Cardinal Health and Telix announce an agreement selecting the former as a commercial radiopharmaceutical distributor to supply finished unit doses…
Some stocks are developing this bullish price pattern, which suggests gains ahead for the names.…
…
…
The Global Burn Care Market Size was Valued at USD 2.41 Billion in 2023 and the Worldwide Burn Care Market…
Cardinal Health announces the opening of its new distribution center in Greenville to support its at-Home Solutions business.…
…
The Global Healthcare Distribution Market Size was Valued at USD 910.45 Billion in 2023 and the Worldwide Healthcare Distribution Market…
Cardinal Healths (CAH) new center is set to integrate cutting-edge technology and automation, enhancing efficiency, storage capacity and quality of…
…
Cardinal Healths (CAH) fourth-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises…
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.…
Cardinal Healths (CAH) fourth-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.…
…
FDA investigations into Cardinal Healths (CAH) China-based syringe manufacturers, Jiangsu Shenli and Jiangsu Caina, reveal significant quality violations, prompting recalls…
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Germany Syringe Market - Forecasts from 2024 to 2029" report…
CODE Das Wertpapier notiert derzeit bei 95,10 US-Dollar. Einen minimalen Wertverlust von 0,21 Prozent zeigt die Kurstafel für die Cardinal…
Several publicly traded drug distributors are vying to buy Florida Cancer Specialists & Research Institute, a privately held operator of…
The Global Closed System Transfer Devices Market Size was Valued at USD 1.3 Billion in 2023 and the Worldwide Closed…
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.…
Chicago, July 09, 2024 (GLOBE NEWSWIRE) -- The "Surgical Suction Instruments Market Size, Share & by Type (Tubes,…
Cardinal Health (CAH) recalls its procedure kits that contain plastic syringes manufactured by a Chinese manufacturer, Jiangsu Shenli.…
…
Am US-amerikanischen Aktienmarkt ist der Anteilsschein von Cardinal Health derzeit unauffällig. Die Aktie kostete zuletzt 104,08 US-Dollar. Kaum auffällig ist…
The Global Breast Biopsy Devices Market Size was Valued at USD 1.7 Billion in 2023 and the Worldwide Breast Biopsy…
…
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. Gross margins improve. However, the rising…
The Global Surgical Wound Care Market Size was Valued at USD 6.12 Billion in 2023 and the Worldwide Surgical Wound…
…
The Global Surgical Gloves Market Size was Valued at USD 2.48 Billion in 2023 and the Worldwide Surgical Gloves Market…
…
Im Minus liegt zur Stunde das Wertpapier von Cardinal Health . Die Aktie notiert gegenwärtig bei 98,75 US-Dollar. Ein Kursverlust…
…
…
Cardinal Healths (CAH) third-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.…
Cardinal Health shares down after losing OptumRx contracts…
Cardinal Health Inc. shares fell the most in more than two months after the drug distributor lost a big contract…
…
Cardinal Health says contracts with UnitedHealths OptumRx will not be renewed…